# Phase ⅡStudy of Pinocembrin Injection to Treat Ischemic Stroke

> **NCT02059785** · PHASE2 · SUSPENDED · sponsor: **CSPC ZhongQi Pharmaceutical Technology Co., Ltd.** · enrollment: 216 (estimated)

## Conditions studied

- Ischemic Stroke

## Interventions

- **DRUG:** Pinocembrin for Injection

## Key facts

- **NCT ID:** NCT02059785
- **Lead sponsor:** CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2013-06
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 216 (ESTIMATED)
- **Last updated:** 2016-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02059785

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02059785, "Phase ⅡStudy of Pinocembrin Injection to Treat Ischemic Stroke". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT02059785. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*